Business Description
Shree Ganesh Biotech (India) Ltd
ISIN : INE051N01026
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.86 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.86 | |||||
Beneish M-Score | -4.43 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.6 | |||||
3-Year EBITDA Growth Rate | 24.1 | |||||
3-Year EPS without NRI Growth Rate | 10.1 | |||||
3-Year FCF Growth Rate | 62.9 | |||||
3-Year Book Growth Rate | 2.9 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 27.91 | |||||
9-Day RSI | 38.66 | |||||
14-Day RSI | 41.46 | |||||
6-1 Month Momentum % | -9.24 | |||||
12-1 Month Momentum % | 42.11 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.35 | |||||
Quick Ratio | 0.35 | |||||
Cash Ratio | 0.04 | |||||
Days Sales Outstanding | 251.4 | |||||
Days Payable | 311.44 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 0.44 | |||||
Operating Margin % | -3.09 | |||||
Net Margin % | 4.55 | |||||
FCF Margin % | 65.2 | |||||
ROE % | 1.13 | |||||
ROA % | 0.93 | |||||
ROIC % | -0.55 | |||||
ROC (Joel Greenblatt) % | 128.43 | |||||
ROCE % | 1.51 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 47.73 | |||||
PE Ratio without NRI | 47.73 | |||||
Shiller PE Ratio | 3.11 | |||||
PEG Ratio | 2.78 | |||||
PS Ratio | 2.69 | |||||
PB Ratio | 0.66 | |||||
Price-to-Tangible-Book | 0.66 | |||||
Price-to-Free-Cash-Flow | 4.12 | |||||
Price-to-Operating-Cash-Flow | 4.12 | |||||
EV-to-EBIT | 43.92 | |||||
EV-to-EBITDA | 43.92 | |||||
EV-to-Revenue | 2.65 | |||||
EV-to-FCF | 4.12 | |||||
Price-to-Projected-FCF | 0.48 | |||||
Price-to-Graham-Number | 1.4 | |||||
Earnings Yield (Greenblatt) % | 2.28 | |||||
FCF Yield % | 24.27 | |||||
Forward Rate of Return (Yacktman) % | 27.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Shree Ganesh Biotech (India) Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 155.8 | ||
EPS (TTM) (₹) | 0.022 | ||
Beta | 2.57 | ||
Volatility % | 110.62 | ||
14-Day RSI | 41.46 | ||
14-Day ATR (₹) | 0.054295 | ||
20-Day SMA (₹) | 1.083 | ||
12-1 Month Momentum % | 42.11 | ||
52-Week Range (₹) | 0.7 - 1.89 | ||
Shares Outstanding (Mil) | 398.62 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shree Ganesh Biotech (India) Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shree Ganesh Biotech (India) Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Shree Ganesh Biotech (India) Ltd Frequently Asked Questions
What is Shree Ganesh Biotech (India) Ltd(BOM:539470)'s stock price today?
When is next earnings date of Shree Ganesh Biotech (India) Ltd(BOM:539470)?
Does Shree Ganesh Biotech (India) Ltd(BOM:539470) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |